Caris Life Sciences — Valuation, Funding & Investors

We're still building this profile — here is what Pulse has covered.

Latest Pulse

Aug 9, 2026Caris Leads a Wild Week for Recent IPO StocksCaris Life Sciences jumped 21.6% on a beat-and-raise quarter while BillionToOne fell 29.8% despite beating estimates, the sharpest split in the Renaissance IPO Index in weeks.→

Coverage Timeline

newest first

Aug 9, 2026IPOCaris Leads a Wild Week for Recent IPO Stocks→

All Coverage

IPO· Aug 9, 2026

Caris Leads a Wild Week for Recent IPO Stocks

IPO

Caris Leads a Wild Week for Recent IPO Stocks

Caris Life Sciences jumped 21.6% on a beat-and-raise quarter while BillionToOne fell 29.8% despite beating estimates, the sharpest split in the Renaissance IPO Index in weeks.

Aug 9, 2026BRIEF

Related Companies

Same sector

Attovia Therapeutics Apnimed Braveheart Bio Latigo Biotherapeutics Scribe Therapeutics